脂肪肝治療の世界市場レポート 2024

脂肪肝治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.3%の年間複合成長率（CAGR）で301億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、病気の有病率の増加、ヘルスケア費の増加、糖尿病やメタボリックシンドロームの発生率の増加、治療法の革新などの要因に起因すると考えられます。予測期間中に予想される注目すべき動向としては、精密医療アプローチの採用、ライフスタイル修正プログラムの実施、非アルコール性脂肪性肝炎（NASH）の標的療法の開発、非侵襲的モニタリングツールの使用、医療分野の技術進歩などが挙げられます。分野。

脂肪肝治療市場は、アルコール消費量の増加傾向によって成長する準備ができています。アルコールを含む飲料の摂取を伴うアルコール消費は、脂肪肝疾患を悪化させ、アルコール性脂肪肝疾患（AFLD）やアルコール性肝炎などの重篤な肝疾患にまでエスカレートすることに関連しています。キリンホールディングス株式会社の2022年12月時点のレポートによると、2021年の世界のビール消費量は約1億8,560万キロリットルで、前年比4.0％増加しました。このアルコール消費量の急増は、脂肪肝治療市場の成長を推進する重要な要因です。

糖尿病の高い有病率は、脂肪肝治療市場の成長に大きく貢献すると予想されます。糖尿病は、人口のかなりの割合が特定の時点で診断されるという特徴を持ち、脂肪肝疾患の発症と進行の顕著な危険因子です。糖尿病患者の代謝不均衡は、肝臓への脂肪の蓄積を引き起こすことがよくあります。 2023年 4月に発表された英国糖尿病協会のデータによると、英国では430万人が糖尿病を患っており、240万人以上が2型糖尿病になるリスクが高いと報告されています。糖尿病の蔓延が脂肪肝治療市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の脂肪肝治療市場、治療タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 拒絶反応抑制薬または免疫抑制薬
• 化学療法薬
• 標的療法
• ワクチン
• 抗ウイルス薬
• 世界の脂肪肝治療市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 肝炎
• 肝臓がん
• 非アルコール性脂肪肝疾患
• その他の疾患
• 世界の脂肪肝治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の脂肪肝治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の脂肪肝治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脂肪肝治療市場の競合情勢
• 脂肪肝治療市場企業プロファイル
  • Prifzer Inc.
  • Johnson &Johnson Services Inc.
  • Hoffmann La Roche Ltd.
  • AstraZeneca plc
  • Merck &Co. Inc.

第31章 その他の大手および革新的な企業

• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• The Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Mitsubishi Chemical Holdings
• Takeda Pharmaceutical Company Limited
• Gilead Sciences Inc.
• Novo Nordisk A/S
• Eisai Co. Ltd.
• Zydus Lifesciences Limited
• Glenmark Pharmaceuticals Limited
• GW Pharmaceuticals Limited
• Retrophin Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Fatty liver disease is a condition characterized by the accumulation of fat in the liver, leading to various symptoms and complications. Fatty liver treatment encompasses multiple strategies, interventions, and actions aimed at addressing and managing this condition.

The primary types of fatty liver treatment include anti-rejection drugs or immunosuppressants, chemotherapy drugs, targeted therapy, vaccines, and anti-viral drugs. Anti-rejection drugs, also known as immunosuppressants, belong to a class of medications designed to suppress or weaken the body's immune response. They are indicated for conditions such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and others. These medications are commonly utilized by hospitals, ambulatory surgery centers, and other healthcare facilities.

The fatty liver treatment market research report is one of a series of new reports from The Business Research Company that provides fatty liver treatment market statistics, including fatty liver treatment industry global market size, regional shares, competitors with a fatty liver treatment market share, detailed fatty liver treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the fatty liver treatment industry. This fatty liver treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fatty liver treatment market size has grown strongly in recent years. It will grow from $22.17 billion in 2023 to $23.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be attributed to factors such as the obesity epidemic, sedentary lifestyles, unhealthy diets, limited treatment options, and awareness campaigns aimed at educating the public about fatty liver disease.

The fatty liver treatment market size is expected to see strong growth in the next few years. It will grow to $30.11 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The anticipated growth in the forecast period can be attributed to factors such as increased disease prevalence, rising healthcare expenditure, the growing incidence of diabetes and metabolic syndrome, and innovations in therapeutics. Notable trends expected in the forecast period include the adoption of precision medicine approaches, the implementation of lifestyle modification programs, the development of targeted therapies for non-alcoholic steatohepatitis (NASH), the use of non-invasive monitoring tools, and technological advancements in the field.

The fatty liver treatment market is poised for growth, driven by the escalating trend in alcohol consumption. Alcohol consumption, involving the intake of beverages containing alcohol, has been linked to exacerbating fatty liver disease and escalating to severe liver conditions such as alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. As of December 2022, a report from Kirin Holdings Company Limited revealed a global beer consumption of about 185.60 million kiloliters in 2021, marking a 4.0% increase from the previous year. This surge in alcohol consumption is a key factor propelling the growth of the fatty liver treatment market.

The high prevalence of diabetes is anticipated to contribute significantly to the growth of the fatty liver treatment market. Diabetes, characterized by a substantial proportion of the population diagnosed at a specific point, is a prominent risk factor for the development and progression of fatty liver disease. Metabolic imbalances in individuals with diabetes often lead to the accumulation of fat in the liver. Data from The British Diabetic Association, published in April 2023, reported that 4.3 million individuals in the UK have diabetes, with more than 2.4 million at high risk of acquiring type 2 diabetes. The prevalence of diabetes is driving the growth of the fatty liver treatment market.

Innovation in product development is a noteworthy trend gaining traction in the fatty liver treatment market. Major companies in this sector are actively working on introducing innovative products to fortify their market positions. For example, Akero Therapeutics, a U.S.-based biotechnology company, reported positive Phase II results for efruxifermin in March 2023. This drug is indicated for the treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Efruxifermin, a differentiated Fc-FGF21 fusion protein, mimics the biological activity of fibroblast growth factor 21 (FGF21), a regulator of multiple metabolic pathways.

Strategic alliances are a pivotal focus for major companies in the fatty liver treatment market to enhance their market positions. These alliances, designed for mutual benefits and market strengthening, come in various forms. In October 2023, Torrent Pharmaceuticals, an India-based pharmaceutical company, formed an agreement with Zydus Lifesciences, another India-based pharmaceutical company. Together, they aimed to co-market a groundbreaking medication for treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). This collaboration, focused on making Saroglitazar Mg more widely accessible in India, secured semi-exclusive rights for Torrent Pharmaceuticals to co-market the product as Vorxar.

In March 2023, Ipsen, a France-based biopharmaceutical company, completed the acquisition of Albireo Pharma Inc. for $952 million. This strategic move significantly expanded Ipsen's portfolio of rare diseases, focusing on unique pipeline potential for therapies in rare cholestatic liver diseases in both children and adults. Albireo Pharma Inc., a U.S.-based biotechnology company, specializes in developing bile acid modulators for the treatment of fatty liver disorders.

Major companies operating in the fatty liver treatment market report are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

North America was the largest region in the fatty liver treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fatty liver treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The fatty liver treatment market consists of revenues earned by entities by providing medical evaluation, medical diagnosis, healthcare provider consultations, nutritional guidance, medication management, ongoing monitoring, and weight management programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The fatty liver treatment market also includes sales of thiazolidinediones, vitamin E, metformin, statins, polyunsaturated fatty acids, angiotensin receptor blockers, and pentoxifylline, which are used in providing fatty liver treatment services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fatty Liver Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fatty liver treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fatty liver treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fatty liver treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants; Chemotherapy Drugs; Targeted Therapy; Vaccines; Anti-Viral Drugs
• 2) By Disease Type: Hepatitis; Liver Cancer; Non-Alcoholic Fatty Liver Disease; Other Diseases
• 3) By End User: Hospitals; Ambulatory Surgery Centers; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Hoffmann La Roche Ltd.; AstraZeneca plc; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fatty Liver Treatment Market Characteristics

3. Fatty Liver Treatment Market Trends And Strategies

4. Fatty Liver Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Fatty Liver Treatment Market Size and Growth

• 5.1. Global Fatty Liver Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Fatty Liver Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Fatty Liver Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fatty Liver Treatment Market Segmentation

• 6.1. Global Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Anti-Rejection Drugs Or Immunosuppressants
• Chemotherapy Drugs
• Targeted Therapy
• Vaccines
• Anti-Viral Drugs
• 6.2. Global Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hepatitis
• Liver Cancer
• Non-Alcoholic Fatty Liver Disease
• Other Diseases
• 6.3. Global Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgery Centers
• Other End Users

7. Fatty Liver Treatment Market Regional And Country Analysis

• 7.1. Global Fatty Liver Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Fatty Liver Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fatty Liver Treatment Market

• 8.1. Asia-Pacific Fatty Liver Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fatty Liver Treatment Market

• 9.1. China Fatty Liver Treatment Market Overview
• 9.2. China Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fatty Liver Treatment Market

• 10.1. India Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fatty Liver Treatment Market

• 11.1. Japan Fatty Liver Treatment Market Overview
• 11.2. Japan Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fatty Liver Treatment Market

• 12.1. Australia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fatty Liver Treatment Market

• 13.1. Indonesia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fatty Liver Treatment Market

• 14.1. South Korea Fatty Liver Treatment Market Overview
• 14.2. South Korea Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fatty Liver Treatment Market

• 15.1. Western Europe Fatty Liver Treatment Market Overview
• 15.2. Western Europe Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fatty Liver Treatment Market

• 16.1. UK Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fatty Liver Treatment Market

• 17.1. Germany Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fatty Liver Treatment Market

• 18.1. France Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fatty Liver Treatment Market

• 19.1. Italy Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fatty Liver Treatment Market

• 20.1. Spain Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fatty Liver Treatment Market

• 21.1. Eastern Europe Fatty Liver Treatment Market Overview
• 21.2. Eastern Europe Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fatty Liver Treatment Market

• 22.1. Russia Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fatty Liver Treatment Market

• 23.1. North America Fatty Liver Treatment Market Overview
• 23.2. North America Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fatty Liver Treatment Market

• 24.1. USA Fatty Liver Treatment Market Overview
• 24.2. USA Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fatty Liver Treatment Market

• 25.1. Canada Fatty Liver Treatment Market Overview
• 25.2. Canada Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fatty Liver Treatment Market

• 26.1. South America Fatty Liver Treatment Market Overview
• 26.2. South America Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fatty Liver Treatment Market

• 27.1. Brazil Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fatty Liver Treatment Market

• 28.1. Middle East Fatty Liver Treatment Market Overview
• 28.2. Middle East Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fatty Liver Treatment Market

• 29.1. Africa Fatty Liver Treatment Market Overview
• 29.2. Africa Fatty Liver Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Fatty Liver Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Fatty Liver Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fatty Liver Treatment Market Competitive Landscape And Company Profiles

• 30.1. Fatty Liver Treatment Market Competitive Landscape
• 30.2. Fatty Liver Treatment Market Company Profiles
  • 30.2.1. Prifzer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Hoffmann La Roche Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AstraZeneca plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Merck & Co. Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Fatty Liver Treatment Market Other Major And Innovative Companies

• 31.1. AbbVie Inc.
• 31.2. Bayer AG
• 31.3. Novartis AG
• 31.4. Sanofi S.A.
• 31.5. The Bristol-Myers Squibb Company
• 31.6. GlaxoSmithKline plc
• 31.7. Mitsubishi Chemical Holdings
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Gilead Sciences Inc.
• 31.10. Novo Nordisk A/S
• 31.11. Eisai Co. Ltd.
• 31.12. Zydus Lifesciences Limited
• 31.13. Glenmark Pharmaceuticals Limited
• 31.14. GW Pharmaceuticals Limited
• 31.15. Retrophin Inc.

32. Global Fatty Liver Treatment Market Competitive Benchmarking

33. Global Fatty Liver Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fatty Liver Treatment Market

35. Fatty Liver Treatment Market Future Outlook and Potential Analysis

• 35.1 Fatty Liver Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Fatty Liver Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Fatty Liver Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer